114 related articles for article (PubMed ID: 16000950)
1. Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy.
Radford KJ; Turtle CJ; Kassianos AJ; Vuckovic S; Gardiner D; Khalil D; Taylor K; Wright S; Gill D; Hart DN
J Immunother; 2005; 28(4):322-31. PubMed ID: 16000950
[TBL] [Abstract][Full Text] [Related]
2. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
3. Single step enrichment of blood dendritic cells by positive immunoselection.
López JA; Bioley G; Turtle CJ; Pinzón-Charry A; Ho CS; Vuckovic S; Crosbie G; Gilleece M; Jackson DC; Munster D; Hart DN
J Immunol Methods; 2003 Mar; 274(1-2):47-61. PubMed ID: 12609532
[TBL] [Abstract][Full Text] [Related]
4. CMRF-56 immunoselected blood dendritic cell preparations activated with GM-CSF induce potent antimyeloma cytotoxic T-cell responses.
Freeman JL; Vari F; Hart DN
J Immunother; 2007 Oct; 30(7):740-8. PubMed ID: 17893566
[TBL] [Abstract][Full Text] [Related]
5. Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma.
Vari F; Munster DJ; Hsu JL; Rossetti TR; Mahler SM; Gray PP; Turtle CJ; Prue RL; Hart DN
Br J Haematol; 2008 Nov; 143(3):374-7. PubMed ID: 18729856
[TBL] [Abstract][Full Text] [Related]
6. Numerical and functional assessment of blood dendritic cells in prostate cancer patients.
Wilkinson R; Kassianos AJ; Swindle P; Hart DN; Radford KJ
Prostate; 2006 Feb; 66(2):180-92. PubMed ID: 16173035
[TBL] [Abstract][Full Text] [Related]
7. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
Ramadan G
Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines.
Ho CS; Munster D; Pyke CM; Hart DN; López JA
Blood; 2002 Apr; 99(8):2897-904. PubMed ID: 11929780
[TBL] [Abstract][Full Text] [Related]
10. Absolute values of dendritic cell subsets in bone marrow, cord blood, and peripheral blood enumerated by a novel method.
Szabolcs P; Park KD; Reese M; Marti L; Broadwater G; Kurtzberg J
Stem Cells; 2003; 21(3):296-303. PubMed ID: 12743324
[TBL] [Abstract][Full Text] [Related]
11. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.
Bauer M; Redecke V; Ellwart JW; Scherer B; Kremer JP; Wagner H; Lipford GB
J Immunol; 2001 Apr; 166(8):5000-7. PubMed ID: 11290780
[TBL] [Abstract][Full Text] [Related]
12. DC in multiple myeloma immunotherapy.
Turtle CJ; Brown RD; Joshua DE; Hart DN
Cytotherapy; 2004; 6(2):128-37. PubMed ID: 15203989
[TBL] [Abstract][Full Text] [Related]
13. Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies.
Ocadlikova D; Kryukov F; Mollova K; Kovarova L; Buresdova I; Matejkova E; Penka M; Buchler T; Hajek R; Michalek J
Neoplasma; 2010; 57(5):455-64. PubMed ID: 20568900
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and functional properties of dendritic cells isolated from human peripheral blood in comparison with mononuclear cells and T cells.
Huang YM; Xiao BG; Westerlund I; Link H
Scand J Immunol; 1999 Feb; 49(2):177-83. PubMed ID: 10075022
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
[TBL] [Abstract][Full Text] [Related]
16. The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population.
Narbutt J; Lesiak A; Zak-Prelich M; Woźniacka A; Sysa-Jedrzejowska A; Tybura M; Robak T; Smolewski P
Cell Mol Biol Lett; 2004; 9(3):497-509. PubMed ID: 15332126
[TBL] [Abstract][Full Text] [Related]
17. CD34+-derived CD11c+ + + BDCA-1+ + CD123+ + DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy.
Ward KA; Stewart LA; Schwarer AP
Cytotherapy; 2006; 8(2):130-40. PubMed ID: 16698686
[TBL] [Abstract][Full Text] [Related]
18. Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors.
Lotem M; Zhao Y; Riley J; Hwu P; Morgan RA; Rosenberg SA; Parkhurst MR
J Immunother; 2006; 29(6):616-27. PubMed ID: 17063124
[TBL] [Abstract][Full Text] [Related]
19. A comparison between isolated blood dendritic cells and monocyte-derived dendritic cells in pigs.
Facci MR; Auray G; Buchanan R; van Kessel J; Thompson DR; Mackenzie-Dyck S; Babiuk LA; Gerdts V
Immunology; 2010 Mar; 129(3):396-405. PubMed ID: 19922422
[TBL] [Abstract][Full Text] [Related]
20. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M
J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
